S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
Freshworks gets juiced on its AI customer engagement platform
Is This The Most Overlooked Gold Investment Strategy of 2024? (Ad)
3 tech outperformers adored by analysts
High short interest stocks: this popular trend is re-emerging
New CBOE “special perk” helps traders target income every weekend (Ad)
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
Boeing glides past series of setbacks on new flight path
Is This The Most Overlooked Gold Investment Strategy of 2024? (Ad)
Fed is set to leave interest rates unchanged while facing speculation about eventual rate cuts
Stock market today: World shares mostly higher after Wall Street hits 2023 peak
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
Freshworks gets juiced on its AI customer engagement platform
Is This The Most Overlooked Gold Investment Strategy of 2024? (Ad)
3 tech outperformers adored by analysts
High short interest stocks: this popular trend is re-emerging
New CBOE “special perk” helps traders target income every weekend (Ad)
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
Boeing glides past series of setbacks on new flight path
Is This The Most Overlooked Gold Investment Strategy of 2024? (Ad)
Fed is set to leave interest rates unchanged while facing speculation about eventual rate cuts
Stock market today: World shares mostly higher after Wall Street hits 2023 peak
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
Freshworks gets juiced on its AI customer engagement platform
Is This The Most Overlooked Gold Investment Strategy of 2024? (Ad)
3 tech outperformers adored by analysts
High short interest stocks: this popular trend is re-emerging
New CBOE “special perk” helps traders target income every weekend (Ad)
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
Boeing glides past series of setbacks on new flight path
Is This The Most Overlooked Gold Investment Strategy of 2024? (Ad)
Fed is set to leave interest rates unchanged while facing speculation about eventual rate cuts
Stock market today: World shares mostly higher after Wall Street hits 2023 peak
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
Freshworks gets juiced on its AI customer engagement platform
Is This The Most Overlooked Gold Investment Strategy of 2024? (Ad)
3 tech outperformers adored by analysts
High short interest stocks: this popular trend is re-emerging
New CBOE “special perk” helps traders target income every weekend (Ad)
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
Boeing glides past series of setbacks on new flight path
Is This The Most Overlooked Gold Investment Strategy of 2024? (Ad)
Fed is set to leave interest rates unchanged while facing speculation about eventual rate cuts
Stock market today: World shares mostly higher after Wall Street hits 2023 peak

Abcam (ABCM) Stock Price, News & Analysis

$23.99
+0.01 (+0.04%)
(As of 12/5/2023)
Compare
Today's Range
$23.98
$24.00
50-Day Range
$22.61
$23.99
52-Week Range
$12.48
$25.32
Volume
7.43 million shs
Average Volume
3.08 million shs
Market Capitalization
$5.50 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$23.00

Abcam MarketRank™ Stock Analysis

Analyst Rating
Hold
2.17 Rating Score
Upside/​Downside
4.1% Downside
$23.00 Price Target
Short Interest
Healthy
2.43% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.55mentions of Abcam in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
29.55%
From $0.44 to $0.57 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.52 out of 5 stars

Medical Sector

856th out of 942 stocks

Biotechnology Industry

31st out of 41 stocks


ABCM stock logo

About Abcam Stock (NASDAQ:ABCM)

Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. The company's principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, biochemicals, and cell signaling pathway tools. It serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. The company has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. It sells its products online. The company was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.

ABCM Stock Price History

ABCM Stock News Headlines

Abcam plc (ABCM) Interactive Stock Chart - Yahoo Finance
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Reviewing aTyr Pharma (NASDAQ:LIFE) & Abcam (NASDAQ:ABCM)
Abcam-Danaher Deal Receives All Identified Clearances - Quick Facts
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Jonathan Milner Issues Statement Responding to ISS Report
Abcam (ABCM) Gets a Hold from RBC Capital
ABCAM INVESTOR ALERT by the Former Attorney...
See More Headlines
Receive ABCM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abcam and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
12/11/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ABCM
Fax
N/A
Employees
1,760
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$23.00
High Stock Price Target
$23.00
Low Stock Price Target
$23.00
Potential Upside/Downside
-4.1%
Consensus Rating
Hold
Rating Score (0-4)
2.17
Research Coverage
6 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$379.70 million
Cash Flow
$0.60 per share
Book Value
$3.92 per share

Miscellaneous

Free Float
213,842,000
Market Cap
$5.50 billion
Optionable
Not Optionable
Beta
0.86
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. Alan Thomas Hirzel BS (Age 55)
    M.B.A., M.S., CEO & Executive Director
    Comp: $1.18M
  • Mr. Michael Shaun Baldock B.A. (Age 59)
    CFO & Director
    Comp: $876.48k
  • Marc Leigh Russell Perkins
    General Counsel & Company Secretary
  • Emma Sceats
    Senior Vice President of Sales & Marketing
  • Mr. Nick Skinner
    Senior Vice President of Human Resources
  • Ms. Alejandra Solache Ph.D.
    Senior Vice President of Research & Development
  • Mr. John Baker
    Senior Vice President of Supply Chain & Manufacturing
  • Juan Carlos Sacristan
    Senior Vice President of Data & Digital














ABCM Stock Analysis - Frequently Asked Questions

Should I buy or sell Abcam stock right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Abcam in the last twelve months. There are currently 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" ABCM shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ABCM, but not buy additional shares or sell existing shares.
View ABCM analyst ratings
or view top-rated stocks.

What is Abcam's stock price target for 2024?

6 Wall Street analysts have issued 1-year target prices for Abcam's stock. Their ABCM share price targets range from $23.00 to $23.00. On average, they anticipate the company's stock price to reach $23.00 in the next twelve months. This suggests that the stock has a possible downside of 4.1%.
View analysts price targets for ABCM
or view top-rated stocks among Wall Street analysts.

How have ABCM shares performed in 2023?

Abcam's stock was trading at $15.56 at the start of the year. Since then, ABCM stock has increased by 54.2% and is now trading at $23.99.
View the best growth stocks for 2023 here
.

Are investors shorting Abcam?

Abcam saw a increase in short interest in November. As of November 15th, there was short interest totaling 5,580,000 shares, an increase of 36.8% from the October 31st total of 4,080,000 shares. Based on an average daily volume of 7,370,000 shares, the short-interest ratio is presently 0.8 days.
View Abcam's Short Interest
.

What ETFs hold Abcam's stock?
When did Abcam IPO?

(ABCM) raised $149 million in an initial public offering (IPO) on Thursday, October 22nd 2020. The company issued 9,000,000 shares at $16.52 per share. Morgan Stanley, BofA Securities, SVB Leerink, Lazard and William Blair served as the underwriters for the IPO.

Who are Abcam's major shareholders?

Abcam's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Baillie Gifford & Co. (3.19%), Soros Fund Management LLC (2.70%), JPMorgan Chase & Co. (2.64%), Brown Advisory Inc. (2.25%), KRYGER CAPITAL Ltd (2.04%) and Wellington Management Group LLP (2.02%).

How do I buy shares of Abcam?

Shares of ABCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:ABCM) was last updated on 12/11/2023 by MarketBeat.com Staff

My Account -